Feasibility of neurocognitive testing in healthy childre
- Conditions
- De gebruikte neurocognitieve testen zijn bruikbaar als biomarker voor centrale effecten van geneesmiddelen in bredere zin. Bij deze pilot is er geen sprake van een specifieke aandoening die bestudeerd wordt.none
- Registration Number
- NL-OMON31940
- Lead Sponsor
- Centre for Human Drug Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 16
Inclusion Criteria
•Age 8-12 years
•Written informed consent from parents having parental responsibility or from the legal guardian. In the case of a child aged 12 years or older the written informed consent of the child is needed in addition to that of parents having responsibility/legal guardian, in the case of a child aged younger than 12 years, assent needs to be provided.
Exclusion Criteria
•Any known psychiatric diagnosis (e.g. autism, oppositional defiant disorder, ADHD)
•Dyslexia
•Learning disability
•Significant behavioural problems
•Use of medication
•Preterm birth
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Results of Neurocognitive tasks:<br /><br><br /><br>- Stroop color-word task<br /><br>- Adaptive tracking<br /><br>- Smooth eye pursuit<br /><br>- Saccadic Eye movements<br /><br>- Finger tapping<br /><br>- Body sway<br /><br><br /><br>Results of a short questionnaire taken after completion of the Neurocognitive<br /><br>tasks.</p><br>
- Secondary Outcome Measures
Name Time Method <p>NA</p><br>